Company Filing History:
1 out of 11 
1 out of 1,179 
Years Active: 2014-2024
Title: Paul Covington: Innovator in Pharmaceutical Formulations
Introduction
Paul Covington is a notable inventor based in Wilmington, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage formulations. With a total of 2 patents, Covington's work focuses on enhancing the efficacy and safety of medications.
Latest Patents
Covington's latest patents include groundbreaking formulations aimed at addressing critical health issues. One of his patents is for opioid receptor modulator dosage formulations, specifically abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, along with processes for their preparation and administration. Another significant patent involves the administration of dipeptidyl peptidase inhibitors, which includes pharmaceutical compositions and methods comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile or a pharmaceutically acceptable salt thereof, administered once weekly.
Career Highlights
Throughout his career, Covington has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Allergan Holdings Unlimited Company and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Covington has collaborated with several professionals in the field, including Tim Costello and Leonard Scott Dove. These partnerships have likely enriched his work and led to innovative solutions in pharmaceutical formulations.
Conclusion
Paul Covington's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of dosage formulations. His patents reflect a commitment to improving medication safety and efficacy. Covington's work continues to influence the pharmaceutical industry positively.